0.25% Bupivacaine Hcl Injection, Solution
Product Images NDC 51662-1606

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for 0.25% Bupivacaine Hcl (NDC 51662-1606). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51662 1396 2 Pouch Labeling

51662 1396 2 Pouch Labeling
This is a description of a medication called 0.5% bupivacaine hydrochloride injection, USP in a 50mL vial, with a concentration of 5mg/mL. The NDC number is 51662-1396-2 and the lot number is 123456, and it is set to expire on January 1st, 2025. It is recommended for nerve block only and not for caudal, epidural or spinal anesthesia. The medication is sterile, nonpyrogenic and the usual dosage and route of administration must be followed as stated in the insert. The medication should be stored at a controlled room temperature of 20° to 25°C and aseptic techniques must be utilized while using the medication. The stopper should be cleansed with antiseptic, and the solution should be clear. The manufacturer's package insert should be consulted for more information. Finally, it is RX Only medication manufactured by HF Acquisition Co. and located in Mukilteo, WA.*
FDA Label Image

51662139622 Bupivacaine Pouch Label

51662139622 Bupivacaine Pouch Label
This is a 50 mL vial of 0.5% bupivacaine hydrochloride injection, US, with a concentration of 5 mg/mL. It is specifically for nerve block and not for caudal, epidural or spinal anesthesia. It is sterile and non-pyrogenic. The usual dosage and route of administration can be found in the insert. The solution should be clear, and the stopper should be cleansed with an antiseptic using aseptic technique. The lot number is 123465, and the expiry date is 2001-03-01. It should be stored at 20° to 25°C (68° to 77°F), and the manufacturer is HF Acquisition Co., LLC, located in Mukilteo, WA 98275. This is a prescription item, and the original manufacturer's NDC number is 0409-1163-01.*
FDA Label Image

51662139639 Bupivacaine Case Label

51662139639 Bupivacaine Case Label
This is a description of a medication called 0.5% Bupivacaine Hydrochloride Injection, the contents of the vial, dosage, and storage instructions. It is primarily used for nerve blocks and must be administered using aseptic technique. However, it is NOT suitable for epidural or spinal anesthesia. The package includes a manufacturer’s insert with detailed information about the product. The medication is manufactured by HF Acquisition Co., LLC, in Mukilteo, WA. The text also includes a lot number, expiration date, and National Drug Code.*
FDA Label Image

51662139639 Bupivacaine Rfid Label

FDA Label Image

Description 1 (Description 1)

Description 1 (Description 1)
This appears to be a chart indicating the concentration of Bupivacaine Hydrochloride and Sodium Chloride in units of milliequivalents per milliliter for different concentrations of the Bupivacaine Hydrochloride solution (0.25%, 0.50%, and 0.75%). It may be useful for medical professionals administering Bupivacaine Hydrochloride solutions to patients.*
FDA Label Image

Description 2 (Description 2)

Description 2 (Description 2)
This is a table displaying the concentration of Bupivacaine HCI, Epinephrine, and Sodium Chloride in milligrams per milliliter (mg/ml) for different dilutions of Bupivacaine. The first column lists the concentration percentages (0.25%, 0.50%, and 0.75%) while the following columns provide the values for the corresponding substances. For the 0.25% dilution, the values are 5 mg/ml for Bupivacaine HCI, 8.5 meg/ml for Epinephrine 1:200,000, and 8.5 mg/ml for Sodium Chloride. The table provides similar information for the other concentrations.*
FDA Label Image

Dosage And Administration (Dosage And Administration)

Dosage And Administration (Dosage And Administration)
This appears to be a table listing different types of anesthesia and the recommended doses for each type based on the type of block and concentration used. The table includes local infiltration, epidural, caudal, and peripheral nerve blocks, among others. It also includes a recommended test dose with epinephrine for epidural anesthesia.*
FDA Label Image

How Supplied 1 (How Supplied 1)

How Supplied 1 (How Supplied 1)
This is a list of Unit of Sale with their respective NDC numbers and Concentrations. The Unit of Sale consists of trays of 25 Single-dose Teartop Vials or Multiple-dose Fliptop Vials. The Concentrations range from 0.25% to 0.75%, and the pH level ranges from 4.0 to 6.5.*
FDA Label Image

How Supplied 2 (How Supplied 2)

FDA Label Image

Indications And Usage (Indications And Usage)

Indications And Usage (Indications And Usage)
This text provides information related to the type and concentration of anesthetic solutions used in different procedures such as local infiltration, peripheral nerve block, retrobulbar block, sympathetic block, lumbar epidural, caudal, epidural test dose and dental blocks. The concentrations used are 0.25%, 0.5% and 0.75%. Additionally, the text highlights that 0.75% concentration is not recommended for obstetrical anesthesia. There is no further information available.*
FDA Label Image
FDA Label Image

Precautions (Precautions)

Precautions (Precautions)
This text provides a list of different drug classes along with examples of drugs that belong to each class. The drug classes include nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs. Examples of drugs in each class are also listed.*
FDA Label Image

Serialized Vial Labeling (Serialized Vial Labeling)

Serialized Vial Labeling (Serialized Vial Labeling)
This text is a mix of various information including a medication called "BuplvaCa'n" with a concentration of 0.5%, its manufacturer's package insert, and a description of a nerve block procedure. The text also contains contact numbers and addresses for certain entities involved in the distribution of the medication. No further information is available.*
FDA Label Image

Structure 1 (Structure 1)

FDA Label Image

Structure 2 (Structure 2)

FDA Label Image

Vial Label (Vial Label)

Vial Label (Vial Label)
This is a description of 0.5% Bupivacaine Hydrochloride Injection, USP, which is used for nerve blocks only. This injection should not be used for caudal, epidural or spinal anesthesia. Each mL contains bupivacaine hydrochloride, anhydrous 5 mg; sodium chloride 8.1 mg; methylparaben 1'mg added as a preservative. This injection may contain NaOH and/or HCl for pH adjustment. It can be stored at 20 to 25°C (68 to 77°F). The usual dosage and route of administration is mentioned in the insert. The LOT number and EXP date is also listed in the text. This product is distributed by Hospira, Inc., Lake Forest, IL 60045 USA.*
FDA Label Image

Boxed Warning (Warnings)

Boxed Warning (Warnings)
The 0.75% concentration of Bupivacaine Hydrochloride is not recommended for obstetrical anesthesia. There have been reports of cardiac arrest or death during use of this drug for epidural anesthesia in obstetrical patients, particularly at the 0.75% concentration. Resuscitation has been difficult or impossible even with adequate preparation and management. Cardiac arrest has occurred after convulsions resulting from systemic toxicity, most likely due to accidental intravascular injection. It’s advisable to reserve the 0.75% concentration for surgical procedures requiring muscle relaxation and prolonged effect.*
FDA Label Image

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.